Terms: = Thyroid cancer AND MYD88, Q99836, MYD88D, 4615
12 results:
1. Association between the expression of TLR4, TLR2, and myd88 with low-grade chronic inflammation in individuals with metabolically healthy obesity.
Guerrero-Romero F; Castellanos-Juárez FX; Salas-Pacheco JM; Morales-Gurrola FG; Salas-Leal AC; Simental-Mendía LE
Mol Biol Rep; 2023 May; 50(5):4723-4728. PubMed ID: 36905405
[TBL] [Abstract] [Full Text] [Related]
2. Curcumin ameliorates oxidized low-density lipoprotein (ox-LDL)-caused damage in human umbilical vein endothelial cells (HUVECs) through the miR-599/myd88/NF-κB axis.
Chen D; Zhu C; Ye S; Yang Q
Toxicol In Vitro; 2022 Dec; 85():105481. PubMed ID: 36156291
[TBL] [Abstract] [Full Text] [Related]
3. Preoperative assessment of cervical lymph node metastases in patients with papillary thyroid carcinoma: Incremental diagnostic value of dual-energy CT combined with ultrasound.
Yoon J; Choi Y; Jang J; Shin NY; Ahn KJ; Kim BS
PLoS One; 2021; 16(12):e0261233. PubMed ID: 34898649
[TBL] [Abstract] [Full Text] [Related]
4. The myd88 inhibitor TJ-M2010-2 suppresses proliferation, migration and invasion of breast cancer cells by regulating myd88/GSK-3β and myd88/NF-κB signalling pathways.
Liu JH; Chen C; Li ZY; Zou ZM; Gao DC; Zhang X; Kuang XW; Sun ZH; Zheng WJ; Zhou P; Sun SR
Exp Cell Res; 2020 Sep; 394(2):112157. PubMed ID: 32610185
[TBL] [Abstract] [Full Text] [Related]
5. MicroRNA-4317 predicts the prognosis of breast cancer and inhibits tumor cell proliferation, migration, and invasion.
Sheng Y; Hu R; Zhang Y; Luo W
Clin Exp Med; 2020 Aug; 20(3):417-425. PubMed ID: 32279128
[TBL] [Abstract] [Full Text] [Related]
6. [Association of Body Mass Index and Risk Stratification of thyroid Nodules in a Multi-center Healthy Population].
Wang Y; Lai XJ; Yang X; Deng XW; Jiang SQ; Yang XW; Tang SQ; Wang J; Ma CM; Li L; Zhang B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Feb; 41(1):93-98. PubMed ID: 30837049
[TBL] [Abstract] [Full Text] [Related]
7. TLR4/myd88 signaling determines the metastatic potential of breast cancer cells.
Wu K; Zhang H; Fu Y; Zhu Y; Kong L; Chen L; Zhao F; Yu L; Chen X
Mol Med Rep; 2018 Sep; 18(3):3411-3420. PubMed ID: 30066873
[TBL] [Abstract] [Full Text] [Related]
8. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
Ollila TA; Olszewski AJ
Curr Treat Options Oncol; 2018 Jun; 19(8):38. PubMed ID: 29931605
[TBL] [Abstract] [Full Text] [Related]
9. Significance of TLR4/myd88 expression in breast cancer.
Chen X; Zhao F; Zhang H; Zhu Y; Wu K; Tan G
Int J Clin Exp Pathol; 2015; 8(6):7034-9. PubMed ID: 26261595
[TBL] [Abstract] [Full Text] [Related]
10. CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-myd88-TAK1-mediated NF-κB and MAPK pathway.
Wang Y; Tu Q; Yan W; Xiao D; Zeng Z; Ouyang Y; Huang L; Cai J; Zeng X; Chen YJ; Liu A
Biochem Biophys Res Commun; 2015 Jan; 456(1):373-9. PubMed ID: 25475726
[TBL] [Abstract] [Full Text] [Related]
11. Oncogenic mutations and chromosomal aberrations in primary extranodal diffuse large B-cell lymphomas of the thyroid--a study of 21 cases.
Knief J; Gebauer N; Bernard V; Schemme J; Reddemann K; Gebauer J; Rades D; Brabant G; Lehnert H; Feller AC; Thorns C
J Clin Endocrinol Metab; 2015 Feb; 100(2):754-62. PubMed ID: 25423572
[TBL] [Abstract] [Full Text] [Related]
12. DNA microarray and miRNA analyses reinforce the classification of follicular thyroid tumors.
Jacques C; Guillotin D; Fontaine JF; Franc B; Mirebeau-Prunier D; Fleury A; Malthiery Y; Savagner F
J Clin Endocrinol Metab; 2013 May; 98(5):E981-9. PubMed ID: 23569218
[TBL] [Abstract] [Full Text] [Related]
